中医药治疗预防新型冠状病毒肺炎用药分析

Study on the Application of Traditional Chinese Medicine in Prevention and Treatment of COVID-19

2019年12月以来,湖北省武汉市发现新型冠状病毒(nCoV-19)引起的肺炎,迅速在全国范围内蔓延。新型冠状病毒属于β属的冠状病毒,具有很强的传染性和传播力,主要通过呼吸道飞沫和接触传播,影响范围广,引起了全世界的高度关注和重视。本文根据《新型冠状病毒肺炎诊疗方案(试行第五版修正版)》《新型冠状病毒肺炎诊疗方案(试行第六版)》《新型冠状病毒肺炎诊疗方案(试行第七版)》的指导意见,查阅文献库,对推荐处方中的常用中药进行分析总结,以期能为临床合理使用中药提供参考。

Since the outbreak in Wuhan,Hubei province on December 2019,nCoV-19 has spread rapidly throughout China.This novel coronavirus belongs to the coronavirus of beta genus,which is highly infectious and transmissible.It mainly spreads through respiratory droplets and contacts,and has a wide range of influence.It has attracted great attention all over the world.According to the Guideline for the Diagnosis and Treatment of Coronavirus(nCoV-19)(trial fifth revision),(trial sixth edition)and(trial seventh edition),we analyzed and summarized the commonly used Chinese medicines in the recommended prescriptions through literature review,so as to provide references for clinical rational use of Chinese medicine.